Antibody–Drug Conjugates for the Treatment of Non-Small Cell Lung Cancer with Central Nervous System Metastases

Antibody–drug conjugates (ADCs) represent an emerging class of targeted anticancer agents that have demonstrated impressive efficacy in numerous cancer types. In non-small cell lung cancer (NSCLC), ADCs have become a component of the treatment armamentarium for a subset of patients with metastatic d...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	David J. H. Bian, Sara F. Cohen, Anna-Maria Lazaratos, Nathaniel Bouganim, Matthew Dankner
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	MDPI AG 2024-10-01
Ráidu:	Current Oncology
Fáttát:	brain metastasis central nervous system metastasis non-small-cell lung cancer lung cancer antibody–drug conjugate ADC
Liŋkkat:	https://www.mdpi.com/1718-7729/31/10/471
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!